Anbio Biotechnology

Anbio Biotechnology (Anbio) is a leading global medical device company with a focus on in vitrodiagnostics. Our goal is to revolutionize the diagnostics market by personalizing and decentralizingcurrent diagnostic solutions, enabling rapid diagnosis and improving patient prognosis. Weachieve this by offering cutting-edge laboratory, wellness, at-home, and point-of-care (POCT) invitro diagnostic (lVD) solutions that are rapid, accessible, and affordable on a global scale. Since its establishment, Anbio has been committed to delivering the most advanced diagnosticsolutions while ensuring cost-effectiveness for our customers. Our extensive capabilities inresearch and development, manufacturing, and global product distribution logistics allowing us tocontinuously focus on cost reduction...

Diagnostic testing,diabetes testing,hormones, infectious disease testing, influenza testing,molecular diagnostics,multiplex testing,point of care testing,rapid tests, thyroid testing,diagnostic tools manufacturer,immunofluorescence, chemiluminescence systems,diagnostic tools manufacturer,equipment manufacturer,analytical instruments, veterinary products,tumor markers/pharmacogenomics,cancer markers,pharmacogenomics, cardiac markers,tumor markers,rna extraction,protein analysis,pregnancy testing,std testing,hpv testing,genetic screening,critical care testing,hepatitis testing,hiv testing,covid, coagulation/hemostasis, cholesterol testing,chemistry testing,and alcohol testing

Anbio biotechnology operates in the Biotechnology research industry.

Anbio biotechnology's revenue is 11m - 100m

Anbio biotechnology has 11 - 50 employees.